.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Covington
Julphar
McKesson
UBS
Deloitte
Mallinckrodt
Citi
Johnson and Johnson

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206075

« Back to Dashboard
NDA 206075 describes CLOBETASOL PROPIONATE, which is a drug marketed by Perrigo Israel, Taro, Ingenus Pharms Llc, Wockhardt, Fougera Pharms, Akorn, Actavis Mid Atlantic, Perrigo Co, G And W Labs Inc, Glenmark Pharms, Mylan Pharms Inc, Lupin Ltd, Teligent Pharma Inc, Novel Labs Inc, Tolmar, Zydus Pharms Usa Inc, Teva Pharms Usa, Fougera Pharms Inc, Paddock Llc, and Novast Labs Ltd, and is included in thirty-eight NDAs. It is available from twenty-seven suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for 206075

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 206075

Medical Subject Heading (MeSH) Categories for 206075

Suppliers and Packaging for NDA: 206075

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE
clobetasol propionate
SOLUTION;TOPICAL 206075 ANDA Novel Laboratories, Inc. 40032-028 40032-028-60 1 BOTTLE in 1 CARTON (40032-028-60) > 50 mL in 1 BOTTLE
CLOBETASOL PROPIONATE
clobetasol propionate
SOLUTION;TOPICAL 206075 ANDA Lupin Pharmaceuticals,Inc. 43386-028 43386-028-60 1 BOTTLE in 1 CARTON (43386-028-60) > 50 mL in 1 BOTTLE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.05%
Approval Date:Nov 23, 2015TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Farmers Insurance
Baxter
Johnson and Johnson
Fuji
UBS
Merck
Federal Trade Commission
Chinese Patent Office
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot